Cystic fibrosis carrier screening is recommended for everyone, but today, 20 years after that recommendation, assays are optimized for a select group – that is largely people of European descent, which can leave people of other ethnic groups behind. There’s a simple reason for this gap – most tests are designed based on variant data that was gathered from almost exclusively European populations. We need to do better.
Register for on-demand webinars about:
C.E. credit is available for all webinars.
The speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here